Hiroo Maeda

Development of a new drug delivery system for protein drugs using silicone (II)

Masako Kajihara, Toshihiko Sugie, Takami Hojo et al. · Journal of Controlled Release · 2001 · 61 citations

Protein Drugs, Engineering, Pharmaceutical Technology +5

A novel transformation of four aldoses to some optically pure pseudohexopyranoses and a pseudopentofuranose, carbocyclic analogs of hexopyranoses and pentofuranose. Synthesis of derivatives of (1S,2S,3R,4S,5S)-, (1S,2S,3R,4R,5S)-, (1R,2R,3R,4R,5S)-, (1S,2S,3R,4S,5R)-2,3,4,5-tetrahydroxy-1-(hydroxymethyl)cyclohexanes and (1S,2S,3S,4S)-2,3,4-trihydroxy-1(hydroxymethyl)cyclopentane

Kin‐ichi Tadano, Hiroo Maeda, M. HOSHINO et al. · The Journal of Organic Chemistry · 1987 · 58 citations

Bioorganic Chemistry, Derivatives, Biochemistry +13

Design of controlled-release formulation for ivermectin using silicone

Hiroo Maeda, Malcolm R. Brandon, Akihiko Sano · International Journal of Pharmaceutics · 2003 · 36 citations

Controlled-release Formulation, Biomedical Engineering, Release Mechanism +1

Selective synthesis of 2,4-bis(O-methoxypolyethylene glycol)-6-chloro-s-triazine as a protein modifier

Kechi Ono, Yoshiyuki Kai, Hiroo Maeda et al. · Journal of Biomaterials Science Polymer Edition · 1991 · 35 citations

Functional Modification, Biochemistry, O-methoxypolyethylene Glycol +11

Controlled release of rhBMP-2 from collagen minipellet and the relationship between release profile and ectopic bone formation

Hiroo Maeda, Akihiko Sano, Keiji Fujioka · International Journal of Pharmaceutics · 2004 · 34 citations

Tissue Engineering, Mechanobiology, Regenerative Medicine +12